Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Isabelle Peguillet

1PUBLICATIONS

60CO-AUTHORS

Cancer diagnosis

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Aug 05, 2022

Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.

Anne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva

Pageof 1

Frequent Collaborators

1 joint publications

Anne-Gaëlle Goubet

1 joint publications

Leonardo Lordello

1 joint publications

Carolina Alves Costa Silva

1 joint publications

Marianne Gazzano

1 joint publications

Maxime Descartes Mbogning-Fonkou

1 joint publications

Cassandra Thelemaque

1 joint publications

Cédric Lebacle

1 joint publications

Constance Thibault

1 joint publications

François Audenet

1 joint publications

Géraldine Pignot

Frequent Collaborators

1 joint publications

Anne-Gaëlle Goubet

1 joint publications

Leonardo Lordello

1 joint publications

Carolina Alves Costa Silva

1 joint publications

Marianne Gazzano

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos